Hanmi Pharmaceutical

Advanced Solid Malignancies

Phase 1

Clinical Trials (1)

NCT02026817Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

Phase 1

HM12460A

Type 2 Diabetes Mellitus

Phase 1

Clinical Trials (1)

NCT03332836Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

Phase 1

HM30181AK tablet + Irinotecan tablets

Phase 1

Clinical Trials (1)

NCT00986843Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

Phase 1

HGP0904

Hypertension(HTN)

Phase 1

Clinical Trials (1)

NCT02387554Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Phase 1

HCP1303

Phase 1

Clinical Trials (1)

NCT02712411Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Phase 1

Amlodipine plus Losartan

Phase 1

Clinical Trials (1)

NCT01197001A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Phase 1

HIP0908

Phase 1

Clinical Trials (1)

NCT01514903Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Phase 1

Amlodipine plus Losartan

Primary Hypercholesterolemia

Phase 1

Clinical Trials (1)

NCT01197014A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Phase 1

HGP0816

Phase 1

Clinical Trials (1)

NCT02941848Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

Phase 1

HM71224 single ascending dose

Rheumatoid Arthritis

Phase 1

Clinical Trials (1)

NCT01765478Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers

Phase 1

HIP1503

Overactive Bladder

Phase 1

Clinical Trials (1)

NCT02940314Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers

Phase 1

HCP1007 / omarco and crestor

Phase 1

Clinical Trials (1)

NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

Phase 1

HCP1201 750/20mg

Phase 1

Clinical Trials (1)

NCT01929512Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

Phase 1

HM12470

Phase 1

Clinical Trials (1)

NCT02302443A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

Phase 1

HCP1303

Advanced Solid Malignancies

Phase 1

Clinical Trials (1)

NCT02715401PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

Phase 1

HM30181AK tablet + Irinotecan tablets

Phase 1

Clinical Trials (1)

NCT00979563Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies

Phase 1

HM11260C

Phase 1

Clinical Trials (1)

NCT02059564A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Phase 1

HM15211 or Placebo

Obesity

Phase 1

Clinical Trials (1)

NCT03374241A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)

Phase 1

Glucophage SR tablet 750 mg, Crestor tablet 20 mg

Phase 1

Clinical Trials (1)

NCT01775579Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium

Phase 1

HCP1201, Fasted followed by fed

Phase 1

Clinical Trials (1)

NCT01901757Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Phase 1

Oratecan and Capecitabine

Solid Tumor

Phase 1

Clinical Trials (1)

NCT01463982Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase 1

HCP0911 / clopidogrel, aspirin

Pulmonary Arterial Hypertension

Phase 1

Clinical Trials (1)

NCT01448330A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Phase 1

HM15275

Obesity

Phase 1

Clinical Trials (2)

NCT07527650Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Phase 2

NCT06481098A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.

Phase 1

HGP1206

Phase 1

Clinical Trials (1)

NCT01864863To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Phase 1

HIP2001

Atrial Fibrillation

Phase 1

Clinical Trials (1)

NCT04764201The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

Phase 1

Levocetirizine

Phase 1

Clinical Trials (1)

NCT01491503A Drug Interaction Study of Montelukast and Levocetirizine

Phase 1

HCP0912 / Irbesartan and Atorvastatin

Phase 1

Clinical Trials (1)

NCT01447797A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Phase 1

montelukast and levocetirizine FDC

Phase 1

Clinical Trials (1)

NCT03371849PK and Safety Study of HCP1102, HGP0813 and HGP1408

Phase 1

Rosuvastatin 20mg

Phase 1

Clinical Trials (1)

NCT02127320Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Phase 1

HM12470

Type1 Diabetes Mellitus

Phase 1

Clinical Trials (1)

NCT03332849Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Phase 1

HCP0910

Asthma

Phase 1

Clinical Trials (1)

NCT01521455Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Phase 1

Tadalafil

Phase 1

Clinical Trials (1)

NCT02239484Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Phase 1

HCP1201 500/10mg

Locally Advanced Solid Tumor

Phase 1

Clinical Trials (1)

NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg

Phase 1

HM95573, cobimetinib

Phase 1

Clinical Trials (1)

NCT03284502HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1

HM10460A or placebo or Neulasta